Page last updated: 2024-11-05

leptophos oxon

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

leptophos oxon: phosvel analog-oxygen substituting sulfur [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID32765
SCHEMBL ID8958565
MeSH IDM0051965

Synonyms (24)

Synonym
ai3-27872
leptophos oxon
leptophosoxon
brn 2947938
phenylphosphonic acid 4-bromo-2,5-dichlorophenyl methyl ester
phosphonic acid, phenyl-, 4-bromo-2,5-dichlorophenyl methyl ester
phosvel oxon
leptophoxon
leptophos oa
1-bromo-2,5-dichloro-4-[methoxy(phenyl)phosphoryl]oxybenzene
25006-32-0
83s10esq22 ,
unii-83s10esq22
SCHEMBL8958565
4-bromo-2,5-dichlorophenyl methyl phenylphosphonate #
MAKUYRKZFGSMMG-UHFFFAOYSA-N
o-methyl o-4-bromo-2,5-dichlorophenyl phenylphosphonate
J-015771
DTXSID40865175
4-bromo-2,5-dichlorophenyl methyl phenylphosphonate
Q27269445
leptophos-oxon
phosphonic acid, p-phenyl-, 4-bromo-2,5-dichlorophenyl methyl ester
AKOS040752486
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (83.33)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.06

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.06 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.14 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.06)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]